This MD&A is based on the Company’s unaudited interim condensed consolidated comparative financial statements for the three-month period ended March 31, 2024 (“consolidated financial statements”) based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”), unless otherwise noted.
Thank You
We’ve received your inquiry. Your question and comments are greatly appreciated. An AGI representative will respond within 3 business days.
